Medrhythms Closes $25M Series B Funding Led By Morningside Ventures And Advantage Capital To Advance Digital Therapeutics Platform
Amount Raised
$25 Million
Round Type
Series B
PortlandInformation TechnologyBiotechnologyDescription
MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, announced today the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. The Company has raised a total of $34 million in gross proceeds from private financings since inception.
Quick answer
MedRhythms raised $25 Million in a Series B round, dated July 28, 2021. MedRhythms is based in Portland, Maine, United States.
- How much did MedRhythms raise?
- MedRhythms raised $25 Million in a Series B round on July 28, 2021.
- What does MedRhythms do?
- MedRhythms is a digital therapeutics company that uses sensors, music and software to build evidence-based neurologic interventions to measure and improve walking.
- Where is MedRhythms based and how big is it?
- MedRhythms is based in Portland, Maine, United States. Fundz records about 26 employees.
- Who are the decision-makers at MedRhythms?
- Fundz holds 1 contact at MedRhythms, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as MedRhythms that raised within 45 days of this round, from Fundz verified event records.
- AVITUS ORTHOPAEDICS, INC. raised $5M on September 10, 2021.
- IntelGenx Technologies Corp. raised $2.1M (Seed) on September 10, 2021.
- Nectero Medical Inc raised $20M (Series C) on September 10, 2021.
- Whitehawk Therapeutics, Inc. raised $155M on September 10, 2021.
- Eclipsebio raised $12M on September 10, 2021.
- Obsidian Therapeutics raised $115M (Series B) on September 9, 2021.
Who to call at MedRhythms, and when
A new round usually means MedRhythms is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MedRhythms raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MedRhythms, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MedRhythms. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MedRhythms raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMedRhythms raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.